Virtual screening and experimental validation of a METTL3-targeting peptide with in vitro antiproliferative activity against non-small cell lung cancer cells

Ying Dai, Hanying Wu, Yahui Shen, Fan Yang, Xiaohao Liu, Ting Zhuang · 2026

Read Virtual screening and experimental validation of a METTL3-targeting peptide with in vitro antiproliferative activity against non-small cell lung cancer cells by Ying Dai, Hanying Wu, Yahui Shen, Fan Yang, Xiaohao Liu, Ting Zhuang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13410616.txt.

Description

Ying Dai and co-workers hunt in 2026 for a peptide that can break up a protein pair driving lung cancer growth. The pair, METTL3 and METTL14, tag RNA in ways that help tumors progress. Blocking their join is a possible drug strategy, though no such drug is in routine use.

Computer screening of a peptide library, followed by docking tests, produced four candidates. The lead peptide bound METTL3 most tightly in lab measures and held a fitting shape in simulations. In lung cancer cells it slowed growth while sparing normal lung cells more. Treated cells showed less of the pair's RNA tagging and lower output of a growth-linked gene. Removing METTL3 blunted the peptide's effect, supporting its aim.

Catalog record

CREATORYing Dai, Hanying Wu, Yahui Shen, Fan Yang, Xiaohao Liu, Ting Zhuang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13410616

Browse the full library · About the Tower of Babel